Fate Therapeutics Inc (FATE)

Market is closed

Insider Trading: Sales

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Chu Officer	$6.52	215	$1,401.80	142,993	2023-04-18	Filing
Redmile Large Shareholder, Director	$5.84	302,339	$1,765,659.76	12,833,419	2023-04-14	Filing
Wolchko Officer, Director	$5.24	45,907	$240,552.68	385,639	2023-01-10	Filing
Valamehr Officer	$5.24	10,917	$57,205.08	168,917	2023-01-10	Filing
Tahl Officer	$5.24	11,553	$60,537.72	177,598	2023-01-10	Filing
Plavsic Officer	$5.24	3,418	$17,910.32	123,705	2023-01-10	Filing
Dulac Officer	$5.24	7,331	$38,414.44	129,470	2023-01-10	Filing
Chu Officer	$5.24	7,825	$41,003.00	143,208	2023-01-10	Filing
Dulac Officer	$30.41	432	$13,137.12	136,801	2022-08-18	Filing
Dulac Officer	$29.75	4,703	$139,914.25	137,233	2022-08-18	Filing
Wolchko Officer, Director	$33.28	620	$20,633.60	431,546	2022-07-22	Filing
Wolchko Officer, Director	$32.61	2,703	$88,144.83	432,166	2022-07-22	Filing
Wolchko Officer, Director	$31.33	2,923	$91,577.59	434,869	2022-07-22	Filing
Wolchko Officer, Director	$33.07	19,171	$633,984.97	431,546	2022-07-21	Filing
Wolchko Officer, Director	$32.54	10,829	$352,375.66	450,717	2022-07-21	Filing
Valamehr Officer	$30.23	17,158	$518,686.34	179,834	2022-07-07	Filing
Valamehr Officer	$30.07	7,842	$235,808.94	179,834	2022-07-06	Filing
Plavsic Officer	$24.61	3,719	$91,524.59	127,123	2022-07-05	Filing
Agarwal Director	$21.89	841	$18,409.49	1,840	2022-06-07	Filing
Agarwal Director	$0.00	0	$0.00	2,681	2022-06-03	Filing